Doxycycline | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Doxycycline
US Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Doxycycline

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

27 API Suppliers, 11 USDMF, 8 CEP/COS, 5 KDMF, 7 NDC API, 13 Listed Suppliers, $ API Reference Price

27 API Suppliers
11 USDMF
8 CEP/COS
5 KDMF
7 NDC API
13 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

15 Drugs in Development

15 Drugs in Development

FINISHED DOSAGE FORMULATIONS

224 FDF Dossiers, 78 FDA Orange Book, 36 Europe, 2 Canada, 58 Australia, 12 South Africa, 38 Listed Dossiers

224 FDF Dossiers
78 FDA Orange Book
36 Europe
2 Canada
58 Australia
12 South Africa
38 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 100MG BASE, CAPSULE;ORAL - EQ 150MG BASE, CAPSULE;ORAL - EQ 50MG BASE, CAPSULE;ORAL - EQ 75MG BASE, CAPSULE;ORAL - 40MG

CAPSULE;ORAL - EQ 100MG BASE
CAPSULE;ORAL - EQ 150MG BASE
CAPSULE;ORAL - EQ 50MG BASE
CAPSULE;ORAL - EQ 75MG BASE
CAPSULE;ORAL - 40MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Evonik, 3 Rochem International Inc, 7 SPI Pharma, 2 Seqens, 9 DKSH, 7 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 11 Actylis, 2 Aeon Procare, 2 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 34 BASF, 1 Clariant, 14 Corel Pharma Chem, 7 DFE Pharma, 3 Finar, 13 Gangwal Chemicals, 11 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 38 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 32 Roquette, 14 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 4 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

85 Fillers, Diluents & Binders, 75 Coating Systems & Additives, 42 Controlled & Modified Release, 40 Disintegrants & Superdisintegrants, 38 Thickeners and Stabilizers, 33 Solubilizers, 32 Direct Compression, 31 Granulation, 29 Film Formers & Plasticizers, 23 Parenteral, 22 Taste Masking, 19 Topical, 17 Lubricants & Glidants, 13 Co-Processed Excipients, 12 Chewable & Orodispersible Aids, 9 Empty Capsules, 8 Emulsifying Agents, 8 Rheology Modifiers, 6 API Stability Enhancers, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

85 Fillers, Diluents & Binders
75 Coating Systems & Additives
42 Controlled & Modified Release
40 Disintegrants & Superdisintegrants
38 Thickeners and Stabilizers
33 Solubilizers
32 Direct Compression
31 Granulation
29 Film Formers & Plasticizers
23 Parenteral
22 Taste Masking
19 Topical
17 Lubricants & Glidants
13 Co-Processed Excipients
12 Chewable & Orodispersible Aids
9 Empty Capsules
8 Emulsifying Agents
8 Rheology Modifiers
6 API Stability Enhancers
5 Surfactant & Foaming Agents
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

47 NEWS #PharmaBuzz

47 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

5 US Medicaid Prescriptions, 51 Finished Drug Prices

5 US Medicaid Prescriptions
51 Finished Drug Prices

MARKET PLACE

37 APIs, 8 FDF Dossiers, 1 Intermediates

37 APIs
8 FDF Dossiers
1 Intermediates

PATENTS & EXCLUSIVITIES

6 US Patents, 3 Health Canada Patents

6 US Patents
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 3 Others

2 EDQM
2 USP
3 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 83 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

6 All

01 6GALDERMA LABS LP

filter Patent Number Reset all filters

6 All

01 17749532

02 18206740

03 18394405

04 18394406

05 18470364

06 18709478

filter API Patent Reset all filters

6 All

01 6Blank

filter FDF Patent Reset all filters

6 All

01 5Y

02 1Blank

filter Expiration Date Reset all filters

6 All

01 42024-04-07

02 12025-12-24

03 12027-12-19

Product Main Page

01

GALDERMA LABS LP

PharmScience R&D

Not Confirmed

GALDERMA LABS LP

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-12-24

DOXYCYCLINE

US Patent Number : 8206740

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50805

Patent Use Code : U-925

Delist Requested :

Patent Use Description : TREATMENT OF ONLY INFL...

Patent Expiration Date : 2025-12-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

GALDERMA LABS LP

PharmScience R&D

Not Confirmed

GALDERMA LABS LP

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-04-07

DOXYCYCLINE

US Patent Number : 8394406

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50805

Patent Use Code : U-925

Delist Requested :

Patent Use Description : TREATMENT OF ONLY INFL...

Patent Expiration Date : 2024-04-07

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

GALDERMA LABS LP

PharmScience R&D

Not Confirmed

GALDERMA LABS LP

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-12-19

DOXYCYCLINE

US Patent Number : 7749532

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50805

Patent Use Code : U-1063

Delist Requested :

Patent Use Description : TREATMENT OF ONLY INFL...

Patent Expiration Date : 2027-12-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

GALDERMA LABS LP

PharmScience R&D

Not Confirmed

GALDERMA LABS LP

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-04-07

DOXYCYCLINE

US Patent Number : 8394405

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50805

Patent Use Code : U-925

Delist Requested :

Patent Use Description : TREATMENT OF ONLY INFL...

Patent Expiration Date : 2024-04-07

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

GALDERMA LABS LP

PharmScience R&D

Not Confirmed

GALDERMA LABS LP

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-04-07

DOXYCYCLINE

US Patent Number : 8470364

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50805

Patent Use Code : U-925

Delist Requested :

Patent Use Description : TREATMENT OF ONLY INFL...

Patent Expiration Date : 2024-04-07

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

GALDERMA LABS LP

PharmScience R&D

Not Confirmed

GALDERMA LABS LP

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-04-07

DOXYCYCLINE

US Patent Number : 8709478

Drug Substance Claim :

Drug Product Claim :

Application Number : 50805

Patent Use Code : U-1063

Delist Requested :

Patent Use Description : TREATMENT OF ONLY INFL...

Patent Expiration Date : 2024-04-07

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!